These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30449067)

  • 41. Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: from 20 to 16 fractions.
    Okada T; Tsuji H; Kamada T; Akakura K; Suzuki H; Shimazaki J; Tsujii H;
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):968-72. PubMed ID: 22898380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carbon ion radiotherapy for locally advanced squamous cell carcinoma of the external auditory canal and middle ear.
    Koto M; Hasegawa A; Takagi R; Sasahara G; Ikawa H; Mizoe JE; Jingu K; Tsujii H; Kamada T; Okamoto Y;
    Head Neck; 2016 Apr; 38(4):512-6. PubMed ID: 25352333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dosimetric parameters predictive of nasolacrimal duct obstruction after carbon-ion radiotherapy for head and neck carcinoma.
    Kubo N; Kubota Y; Kawamura H; Oike T; Sakai M; Kumazawa T; Miyasaka Y; Okazaki S; Kobayashi D; Sato H; Mizukami T; Musha A; Shirai K; Saitoh JI; Yokoo S; Chikamatsu K; Ohno T; Nakano T
    Radiother Oncol; 2019 Dec; 141():72-77. PubMed ID: 31439449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carbon-ion Radiotherapy for Isolated Lymph Node Metastasis After Surgery or Radiotherapy for Lung Cancer.
    Shirai K; Kubota Y; Ohno T; Saitoh JI; Abe T; Mizukami T; Mori Y; Kawamura H; Akahane K; Nakano T
    Front Oncol; 2019; 9():731. PubMed ID: 31448233
    [No Abstract]   [Full Text] [Related]  

  • 46. Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?
    Jensen AD; Poulakis M; Vanoni V; Uhl M; Chaudhri N; Federspil PA; Freier K; Krauss J; Debus J
    Radiat Oncol; 2016 Jul; 11(1):90. PubMed ID: 27386864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.
    Askoxylakis V; Hegenbarth P; Timke C; Saleh-Ebrahimi L; Debus J; Röder F; Huber PE
    Radiat Oncol; 2016 Feb; 11():17. PubMed ID: 26847089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carbon Ion irradiation in the treatment of grossly incomplete or unresectable malignant peripheral nerve sheaths tumors: acute toxicity and preliminary outcome.
    Jensen AD; Uhl M; Chaudhri N; Herfarth KK; Debus J; Roeder F
    Radiat Oncol; 2015 May; 10():109. PubMed ID: 25943106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unexpected radiation laryngeal necrosis after carbon ion therapy using conventional dose fractionation for laryngeal cancer.
    Demizu Y; Fujii O; Nagano F; Terashima K; Jin D; Mima M; Oda N; Takeuchi K; Takeda M; Ito K; Fuwa N; Okimoto T
    Jpn J Clin Oncol; 2015 Nov; 45(11):1076-81. PubMed ID: 26355161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Feasibility of carbon-ion radiotherapy for re-irradiation of locoregionally recurrent, metastatic, or secondary lung tumors.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Tsuji H; Ogawa K; Kamada T
    Cancer Sci; 2018 May; 109(5):1562-1569. PubMed ID: 29498145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.
    Jensen AD; Poulakis M; Nikoghosyan AV; Chaudhri N; Uhl M; Münter MW; Herfarth KK; Debus J
    Radiother Oncol; 2015 Feb; 114(2):182-8. PubMed ID: 25640299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Outcomes of Intensity-modulated Carbon-ion Radiotherapy for Bone and Soft Tissue Tumors.
    Takakusagi Y; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Kamada T; Katoh H
    Anticancer Res; 2023 Jun; 43(6):2777-2781. PubMed ID: 37247930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical trial of prophylactic extended-field carbon-ion radiotherapy for locally advanced uterine cervical cancer (protocol 0508).
    Wakatsuki M; Kato S; Kiyohara H; Ohno T; Karasawa K; Tamaki T; Ando K; Tsujii H; Nakano T; Kamada T; Shozu M;
    PLoS One; 2015; 10(5):e0127587. PubMed ID: 25993047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term Outcomes of Carbon-ion Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Uterine Cervix.
    Okonogi N; Wakatsuki M; Kato S; Shiba S; Kobayashi D; Kiyohara H; Karasawa K; Ohno T; Nakano T; Kamada T; Shozu M;
    Anticancer Res; 2018 Jan; 38(1):457-463. PubMed ID: 29277809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical outcomes of carbon-ion radiotherapy for locally advanced non-small-cell lung cancer.
    Hayashi K; Yamamoto N; Nakajima M; Nomoto A; Tsuji H; Ogawa K; Kamada T
    Cancer Sci; 2019 Feb; 110(2):734-741. PubMed ID: 30467928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dose-escalation study of carbon ion radiotherapy for locally advanced squamous cell carcinoma of the uterine cervix (9902).
    Wakatsuki M; Kato S; Ohno T; Karasawa K; Ando K; Kiyohara H; Tsujii H; Nakano T; Kamada T; Shozu M;
    Gynecol Oncol; 2014 Jan; 132(1):87-92. PubMed ID: 24183732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment outcomes of particle radiotherapy using protons or carbon ions as a single-modality therapy for adenoid cystic carcinoma of the head and neck.
    Takagi M; Demizu Y; Hashimoto N; Mima M; Terashima K; Fujii O; Jin D; Niwa Y; Morimoto K; Akagi T; Daimon T; Sasaki R; Hishikawa Y; Abe M; Murakami M; Fuwa N
    Radiother Oncol; 2014 Dec; 113(3):364-70. PubMed ID: 25467004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Results of carbon ion radiotherapy in 152 patients.
    Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Kraft G; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):631-40. PubMed ID: 14751537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
    Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.
    Mohamad O; Tabuchi T; Nitta Y; Nomoto A; Sato A; Kasuya G; Makishima H; Choy H; Yamada S; Morishima T; Tsuji H; Miyashiro I; Kamada T
    Lancet Oncol; 2019 May; 20(5):674-685. PubMed ID: 30885458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.